214 related articles for article (PubMed ID: 30295208)
1. Mood stabilisers and risk of stroke in bipolar disorder.
Chen PH; Tsai SY; Pan CH; Chang CK; Su SS; Chen CC; Kuo CJ
Br J Psychiatry; 2019 Jul; 215(1):409-414. PubMed ID: 30295208
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic drugs, mood stabilizers, and risk of pneumonia in bipolar disorder: a nationwide case-control study.
Yang SY; Liao YT; Liu HC; Chen WJ; Chen CC; Kuo CJ
J Clin Psychiatry; 2013 Jan; 74(1):e79-86. PubMed ID: 23419234
[TBL] [Abstract][Full Text] [Related]
3. Associations between use of mood stabilizers and risk of cataract: A population-based nested case-control study.
Chu CS; Lin CH; Lan TH; Chou PH
J Affect Disord; 2018 Feb; 227():79-81. PubMed ID: 29053979
[TBL] [Abstract][Full Text] [Related]
4. Association of Lithium Treatment With the Risk of Osteoporosis in Patients With Bipolar Disorder.
Köhler-Forsberg O; Rohde C; Nierenberg AA; Østergaard SD
JAMA Psychiatry; 2022 May; 79(5):454-463. PubMed ID: 35353126
[TBL] [Abstract][Full Text] [Related]
5. The role of mood stabilisers in the treatment of the depressive facet of bipolar disorders.
Bourin M; Prica C
Neurosci Biobehav Rev; 2007; 31(6):963-75. PubMed ID: 17462734
[TBL] [Abstract][Full Text] [Related]
6. Psychotropic use and risk of stroke among patients with bipolar disorders: 10-year nationwide population based study.
Wu CS; Wu KY; Lo YR; Huang YW; Tsai YT; Li Y; Tsai HJ
J Affect Disord; 2018 Jan; 226():77-84. PubMed ID: 28964996
[TBL] [Abstract][Full Text] [Related]
7. Management of adverse effects of mood stabilizers.
Murru A; Popovic D; Pacchiarotti I; Hidalgo D; León-Caballero J; Vieta E
Curr Psychiatry Rep; 2015 Aug; 17(8):603. PubMed ID: 26084665
[TBL] [Abstract][Full Text] [Related]
8. Lithium versus anticonvulsants and the risk of physical disorders - Results from a comprehensive long-term nation-wide population-based study emulating a target trial.
Kessing LV; Knudsen MB; Rytgaard HCW; Torp-Pedersen C; Berk M
Eur Neuropsychopharmacol; 2024 Jul; 84():48-56. PubMed ID: 38663126
[TBL] [Abstract][Full Text] [Related]
9. Lamotrigine combined with divalproex or lithium for bipolar disorder: a case series.
Redmond JR; Jamison KL; Bowden CL
CNS Spectr; 2006 Dec; 11(12):915-8. PubMed ID: 17146405
[TBL] [Abstract][Full Text] [Related]
10. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
[TBL] [Abstract][Full Text] [Related]
11. Oxcarbazepine for acute affective episodes in bipolar disorder.
Vasudev A; Macritchie K; Vasudev K; Watson S; Geddes J; Young AH
Cochrane Database Syst Rev; 2011 Dec; (12):CD004857. PubMed ID: 22161387
[TBL] [Abstract][Full Text] [Related]
12. Diabetes mellitus risk for 102 drugs and drug combinations used in patients with bipolar disorder.
Nestsiarovich A; Kerner B; Mazurie AJ; Cannon DC; Hurwitz NG; Zhu Y; Nelson SJ; Oprea TI; Crisanti AS; Tohen M; Perkins DJ; Lambert CG
Psychoneuroendocrinology; 2020 Feb; 112():104511. PubMed ID: 31744781
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological treatment of bipolar disorder and risk of diabetes mellitus: A nationwide study of 30,451 patients.
Rohde C; Köhler-Forsberg O; Nierenberg AA; Østergaard SD
Bipolar Disord; 2023 Jun; 25(4):323-334. PubMed ID: 36751986
[TBL] [Abstract][Full Text] [Related]
14. [Anticonvulsants in the treatment of bipolar disorder].
Grunze H
Neuropsychiatr; 2007; 21(2):110-20. PubMed ID: 17640497
[TBL] [Abstract][Full Text] [Related]
15. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
Macritchie KA; Geddes JR; Scott J; Haslam DR; Goodwin GM
Cochrane Database Syst Rev; 2001; (3):CD003196. PubMed ID: 11687047
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial comparing lithium plus valproic acid versus lithium plus carbamazepine in young patients with type 1 bipolar disorder: the LICAVAL study.
Missio G; Moreno DH; Demetrio FN; Soeiro-de-Souza MG; Dos Santos Fernandes F; Barros VB; Moreno RA
Trials; 2019 Oct; 20(1):608. PubMed ID: 31655626
[TBL] [Abstract][Full Text] [Related]
17. The place of anticonvulsants and other putative mood stabilisers in the treatment of bipolar disorder.
Mitchell PB
Aust N Z J Psychiatry; 1999 Dec; 33 Suppl():S99-107. PubMed ID: 10622184
[TBL] [Abstract][Full Text] [Related]
18. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
19. The rapid suicide protection of mood stabilizers on patients with bipolar disorder: A nationwide observational cohort study in Taiwan.
Tsai CJ; Cheng C; Chou PH; Lin CH; McInnis MG; Chang CL; Lan TH
J Affect Disord; 2016 May; 196():71-7. PubMed ID: 26919054
[TBL] [Abstract][Full Text] [Related]
20. Safety and tolerability of mood-stabilising anticonvulsants in the elderly.
Fenn HH; Sommer BR; Ketter TA; Alldredge B
Expert Opin Drug Saf; 2006 May; 5(3):401-16. PubMed ID: 16610969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
